PurMinds Eyes Market Upgrade with $2.25M Boost

PurMinds Enterprises has filed its financials for the second quarter of 2026 and is gearing up for a PCAOB audit. The company is keen on moving to a higher market tier and has been busy cleaning up its financial mess from the past, while also pulling in over $2.25 million in fresh capital. The goal is to focus on their neurological drug pipeline and diagnostic tools. What does it mean for you? If you're an investor or thinking about becoming one, this cleanup and audit could mean a more transparent and stable company, possibly making it a safer investment option in the biotech field.